Mobius Medical awarded Phase I SBIR funding from the National Institutes of Health to improve safety of radiation treatments

Mobius Medical Systems, LP, the leader in innovative software for quality assurance (QA) in radiation oncology, has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH). During the six-month project, Mobius Medical will collaborate with Dr. Jonas Fontenot of Mary Bird Perkins Cancer Center in Baton Rouge, LA, to develop and validate a fully-automated framework for verifying that each radiation therapy treatment is delivered as intended.

“This company was founded with a mission of providing clinicians with innovative software tools needed to ensure the safe and successful delivery of radiation treatments,” said Dr. Nathan Childress, founder of Mobius Medical. “We are pleased to have NIH support of our mission and look forward to a successful collaboration with Dr. Fontenot on this project.”

“There is an urgent need for efficient QA tools to complement increasingly complex radiation therapy treatments,” said Dr. Fontenot. “The ability to quantify and monitor the cumulative delivered dose over the course of a treatment is a significant step forward. I am excited to assist Mobius Medical with this project, which will bring significant improvements in safety to radiation therapy patients worldwide.”